Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

Key facts

Sponsor

Davinci LTD

Intervention

Suprachoroidal silicone tube (SST) shunt(device)

Enrollment

66 target

Eligibility

40-90 years · All sexes

Timeline

2024 – 2024

Study locations (1)

• Davinci Eye Center, LTD, Tbilisi, Georgia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2, PHASE3NCT07354516
  Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
  Qlaris Bio, Inc.
• RECRUITINGNCT07303257
  Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
  Hospices Civils de Lyon
• RECRUITINGPHASE1, PHASE2NCT06921317
  GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
  IVIEW Therapeutics Inc.
• ACTIVE NOT RECRUITINGPHASE3NCT07082816
  Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
  Alcon Research
• ACTIVE NOT RECRUITINGPHASE2NCT06030193
  Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)
  Qlaris Bio, Inc.
• RECRUITINGNANCT06682962
  Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
  Okuvision GmbH
• RECRUITINGPHASE4NCT06848946
  Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
  Glaukos Corporation
• RECRUITINGNANCT06607705
  Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor
  Fundacio Privada Mon Clinic Barcelona

See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma →